An increased cancer risk in post-menopausal women after they stopped taking combined hormone therapy was an ?unexpected finding? in a study that will be reported in the March 5 edition of the Journal of the American Medical Association (JAMA), said Rowan T. Chlebowski, M.D., Ph.D., a Los Angeles Biomedical Research Institute (LA BioMed) lead investigator who contributed to the study.
More...